Search Articles
SAN MATEO, Calif. – A multiple sclerosis patient claims she got malignant myeloma from taking Biogen Idec’s and Elan Pharmaceuticals’ drug Tysabri (natalizumab).
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.